Thousands with high cholesterol set to benefit from new treatment on the NHS

Thousands with high cholesterol set to benefit from new treatment on the NHS Around 70,000 adults in England with primary hypercholesterolaemia or mixed dyslipidaemia, also known as high cholesterol, will now be eligible for treatment with bempedoic acid with ezetimibe, if statins cannot be taken, or have not worked for themas a result of final NICE guidance published today.